Spotlight

UCL cancer immunotherapy company, Autolus, launches with £30m investment

A new UCL spin-out company – Autolus – is being launched today to develop and commercialise a new generation of engineered T-cell therapies for haematological and solid tumours, with the backing of £30m in investment from healthcare investment company Syncona.

Find out more



follow us on twitter


Archive of News

<< 2011 Jan Feb Mar Apr May Jun Jul Aug Sep Oct Nov Dec 2013 >>

18 June 2012: BHP Billiton Named UCL Enterprise Partner of the Year 2012

BHP Billiton have been named UCL Enterprise Partner of the Year in recognition of their strong collaborative work with UCL. This follows the agreement signed in June 2011 to establish Institutes in London and Adelaide. More...

<< 2011 Jan Feb Mar Apr May Jun Jul Aug Sep Oct Nov Dec 2013 >>